Drug Information

Drug General Information
Drug ID
D0G9UX
Former ID
DNC000412
Drug Name
CGS 35066
Drug Type
Small molecular drug
Indication Discovery agent Investigative [535609]
Structure
Download
2D MOL

3D MOL
Formula
C16H16NO6P
Canonical SMILES
C1=CC=C2C(=C1)C3=C(O2)C=C(C=C3)CC(C(=O)O)NCP(=O)(O)O
InChI
1S/C16H16NO6P/c18-16(19)13(17-9-24(20,21)22)7-10-5-6-12-11-3-1-2-4-14(11)23-15(12)8-10/h1-6,8,13,17H,7,9H2,(H,18,19)(H2,20,21,22)
InChIKey
CRUVAUSVWLATAE-UHFFFAOYSA-N
PubChem Compound ID
24868306
PubChem Substance ID
50112891, 57160273, 103211317, 230476569
Target and Pathway
Target(s) Endothelin-converting enzyme 1 Target Info Inhibitor [535609]
Endothelin-converting enzyme 2 Target Info Inhibitor [535609]
PANTHER Pathway Endothelin signaling pathwayP00019:Endothelin signaling pathway
WikiPathways SIDS Susceptibility Pathways
Corticotropin-releasing hormone
Endothelin Pathways
References
Ref 535609The therapeutic potential of endothelin-1 receptor antagonists and endothelin-converting enzyme inhibitors on the cardiovascular system. Expert Opin Investig Drugs. 2002 Nov;11(11):1537-52.
Ref 535609The therapeutic potential of endothelin-1 receptor antagonists and endothelin-converting enzyme inhibitors on the cardiovascular system. Expert Opin Investig Drugs. 2002 Nov;11(11):1537-52.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.